If the answer is Yes to Box 24, then Box 25, in the shape of a rectangle: Follow up annually or more frequently as dictated by comorbid conditions (to include lab monitoring, if indicated) b. If the answer is No to Box 24, then Box 22, in the shape of a rectangle: Consider offering and/or adjusting HBPM with co-interventions (tailored medication titration, education, and/or lifestyle counseling) Appendix L: Abbreviations Abbreviation Definition AASK African American Study of Kidney Disease and Hypertension AA aldosterone antagonist ABI ankle-brachial index ABPM ambulatory blood pressure monitoring ACC American College of Cardiology ACCOMPLISH Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension ACCORD Action to Control Cardiovascular Risk in Diabetes ACEI angiotensin-converting enzyme inhibitor ADVANCE Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation AE adverse effect AHA American Heart Association AHRQ Agency for Healthcare Research and Quality ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack ( AOBP automated office blood pressure ARB angiotensin II receptor blocker AUC area under curve AV atrioventricular bid twice daily BMI body mass index BPH benign prostatic hyperplasia BPROAD Blood Pressure Control Target in Diabetes CAC coronary artery calcification CAD coronary artery disease CCB calcium channel blocker CHF chronic heart failure CKD chronic kidney disease cm centimeter CMS Centers for Medicare and Medicaid Services COB central operating base COI conflict of interest COR contracting officer's representative CPG clinical practice guideline CS clinical study CV cardiovascular CVD cardiovascular disease DASH Dietary Approaches to Stop Hypertension DBP diastolic blood pressure DHP dihydropyridines Abbreviation Definition DoD Department of Defense DRI direct renin inhibitors EBPWG Evidence-Based Practice Work Group ECG electrocardiogram ECHO echocardiogram eGFR estimated glomerular filtration rate EKG electrocardiogram FDA U.S. Food and Drug Administration FOB forward operating base GI gastrointestinal GRADE Grading of Recommendations Assessment, Development and Evaluation HBPM home blood pressure monitoring HC high-unrefined carbohydrate, low-fat diet HCTZ hydrochlorothiazide HEC Health Executive Committee HFrEF reduced ejection fraction HIPAA Health Insurance Portability and Accountability Act HTN hypertension HYVET Hypertension in the Very Elderly Trial IPAD Intervention for High-normal or Borderline-elevated Blood Pressure in Adults with Type 2 Diabetes IR immediate release Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure K+ Potassium KQ key question LA DHP long-acting dihydropyridine LC low-carbohydrate, high-unsaturated/low-saturated fat diet LDL low-density lipoprotein LIFE Losartan Intervention For Endpoint reduction LV left ventricular LVH left ventricular hypertrophy MACE major adverse cardiovascular events MD mean difference MHS Military Health System MI myocardial infarction mL milliliter MRA mineralocorticoid receptor antagonist MRC Medical Research Council MRE Meals Ready to Eat MTF military treatment facilities Abbreviation Definition NHANES National Health and Nutrition Examination Survey NICE National Institute for Health and Care Excellence NPV negative predictive value OSA obstructive sleep apnea PCC patient-centered care PICOTS population, intervention, comparison, outcome, timing and setting PPV positive predictive value PREDIMED PREvenci n con DIeta MEDiterr nea PVD perpherial vascular disease RCT randomized control trial RHT resistant hypertension SBP systolic blood pressure SDM shared decision making SLE systemic lupus erythematosus SME subject matter expert SMS short message service SPRINT Systolic Blood Pressure Intervention Trial SR systematic review Tbsp tablespoon TOHP II Trials of Hypertension Prevention Phase II TONE Trial of Non-pharmacologic Interventions in the Elderly TOPCAT Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial U.S. United States US ultrasound USPSTF U.S. Preventive Services Task Force VA Veterans Affairs VHA Veterans Health Administration References 1. 